US Patent 11510939 RNAs for complement inhibition
Patent 11510939 was granted and assigned to Apellis Pharmaceuticals on November, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
April 20, 2020
Date of Patent
November 29, 2022
Patent Applicant
Patent Application Number
16853732
Patent Jurisdiction
Patent Number
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11510939 RNAs for complement inhibition
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.